Intravenous Immunoglobulins for Prevention of BKV Infection in Kidney Transplant Recipients According to BKV Genotype-specific Neutralizing Antibody Titers at the Day of Transplantation.
Clinical trial NCT04222023 · COMPLETED
Trial details
- NCT number
- NCT04222023
- Sponsor
- University Hospital, Strasbourg, France
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-21
- Primary completion
- 2026-08-01
- Enrollment
- 359
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.